DE602005014386D1 - Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome - Google Patents

Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome

Info

Publication number
DE602005014386D1
DE602005014386D1 DE602005014386T DE602005014386T DE602005014386D1 DE 602005014386 D1 DE602005014386 D1 DE 602005014386D1 DE 602005014386 T DE602005014386 T DE 602005014386T DE 602005014386 T DE602005014386 T DE 602005014386T DE 602005014386 D1 DE602005014386 D1 DE 602005014386D1
Authority
DE
Germany
Prior art keywords
cyfra
osteopontin
marker
colorectal cancer
colorectal carcinomas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005014386T
Other languages
English (en)
Inventor
Werner Zolg
Wolfgang Rollinger
Veit Grunert
Herbert Andres
Johann Karl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Roche Diagnostics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics GmbH filed Critical Roche Diagnostics GmbH
Publication of DE602005014386D1 publication Critical patent/DE602005014386D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4742—Keratin; Cytokeratin
DE602005014386T 2004-12-23 2005-12-22 Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome Active DE602005014386D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04030619 2004-12-23
PCT/EP2005/013867 WO2006066915A1 (en) 2004-12-23 2005-12-22 Use of cyfra 21-1 as a marker for colorectal cancer

Publications (1)

Publication Number Publication Date
DE602005014386D1 true DE602005014386D1 (de) 2009-06-18

Family

ID=34927964

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005014386T Active DE602005014386D1 (de) 2004-12-23 2005-12-22 Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome

Country Status (10)

Country Link
US (1) US7731938B2 (de)
EP (1) EP1831695B1 (de)
JP (1) JP4606469B2 (de)
CN (2) CN101088011B (de)
AT (1) ATE430936T1 (de)
CA (1) CA2585788C (de)
DE (1) DE602005014386D1 (de)
ES (1) ES2325277T3 (de)
HK (1) HK1115636A1 (de)
WO (1) WO2006066915A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100021928A1 (en) * 2006-06-26 2010-01-28 Technion Research & Development Foundation Ltd. Methods and kits for diagnosing cancer
DE602007006671D1 (de) * 2006-08-01 2010-07-01 Roche Diagnostics Gmbh Verwendung von nnmt als marker für lungenkrebs
US20100196889A1 (en) * 2006-11-13 2010-08-05 Bankaitis-Davis Danute M Gene Expression Profiling for Identification, Monitoring and Treatment of Colorectal Cancer
ES2527649T3 (es) * 2007-12-10 2015-01-28 F. Hoffmann-La Roche Ag Panel de marcadores para el cáncer colorrectal
EP2297581B1 (de) 2008-07-03 2013-04-03 F. Hoffmann-La Roche AG Asc als lungenkrebsmarker
US9075060B2 (en) * 2009-06-16 2015-07-07 Technion Research & Development Foundation Limited Methods for diagnosing oral or oral-pharyngeal cancer
US20130095503A1 (en) * 2010-01-05 2013-04-18 University Of Cincinnati Serum spla2-iia as diagnosis marker for prostate and lung cancer
CN106706914B (zh) 2010-09-09 2018-10-19 北京同为时代生物技术有限公司 用于诊断上皮源性癌症的血液标志物及单克隆抗体
JP5976695B2 (ja) 2011-03-11 2016-08-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 慢性閉塞性肺疾患（ｃｏｐｄ）のマーカーとしてのａｓｃ
US9725491B2 (en) * 2012-04-24 2017-08-08 Bogazici Universitesi Method for antigen delivery
KR101619122B1 (ko) 2013-08-14 2016-05-10 연세대학교 산학협력단 탈메틸화 의존적 ａｓｃ 발현을 촉진시켜서 대장암 종양세포의 사멸감수성을 증진시키는 항암제 병용 투여용 후보물질의 스크리닝 방법
US20160178631A1 (en) * 2014-08-22 2016-06-23 Abbott Laboratories Methods for the early detection of colorectal cancer
WO2019120527A1 (en) * 2017-12-20 2019-06-27 Michael Heneka Novel means and methods for treating neurodegenerative diseases
KR102293271B1 (ko) * 2019-02-25 2021-08-23 가톨릭대학교 산학협력단 Cyfra 21-1을 이용한 갑상선암 림프절 전이 진단 방법
ES2952139T3 (es) * 2019-03-01 2023-10-27 Advanced Marker Discovery S L Firma proteica para el diagnóstico de cáncer colorrectal y/o etapa precancerosa del mismo
WO2021185982A1 (en) * 2020-03-19 2021-09-23 Advanced Marker Discovery S.l. Protein signature for screening general population for colorectal cancer and/or pre-cancerous stage thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6165740A (en) * 1998-09-30 2000-12-26 Sysmex Corporation Method and device for flow-cytometric microorganism analysis
US7118912B2 (en) * 2002-08-26 2006-10-10 Case Western Reserve University Methods and compositions for categorizing patients
JP2004198419A (ja) * 2002-12-13 2004-07-15 Bayer Healthcare Llc Ｔｉｍｐ１を用いた検出方法
CA2510377C (en) * 2002-12-20 2009-11-17 F. Hoffmann-La Roche Ag Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
CA2523690C (en) * 2003-05-26 2011-05-03 F. Hoffmann-La Roche Ag Use of protein masp as a marker for colorectal cancer

Also Published As

Publication number Publication date
CA2585788C (en) 2013-03-05
CA2585788A1 (en) 2006-06-29
CN101088011A (zh) 2007-12-12
CN101088011B (zh) 2012-07-18
US20080020414A1 (en) 2008-01-24
ES2325277T3 (es) 2009-08-31
EP1831695A1 (de) 2007-09-12
EP1831695B1 (de) 2009-05-06
JP4606469B2 (ja) 2011-01-05
US7731938B2 (en) 2010-06-08
HK1115636A1 (en) 2008-12-05
ATE430936T1 (de) 2009-05-15
WO2006066915A1 (en) 2006-06-29
JP2008522172A (ja) 2008-06-26
CN101088012A (zh) 2007-12-12

Similar Documents

Publication Publication Date Title
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
ATE554389T1 (de) Apex als marker für lungenkrebs
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도
SG10201408392PA (en) Methods of determining patient response by measurement of her-3
ATE527543T1 (de) Testvorrichtung zur schnelldiagnose
WO2009074276A3 (en) Marker panel for colorectal cancer
DE60332639D1 (de) Verwendung von biomarkern zum nachweis von eierstockkrebs
ATE449865T1 (de) Teststreifen zum analytnachweis und verwendungsverfahren
BRPI0814201A2 (pt) Sistema e método de análise de produto de análise em amostra fluida e meio legível em computador
DE602005013225D1 (de) Aptamer-nanopartikelkonjugate und verwendungsverfahren zur detektion von zielanalyten
CY1122022T1 (el) Αναπτυξη και χρηση φθοριζοντων ανιχνευτων αδεσμευτης χολερυθρινης
DK1889059T3 (da) Fremgangsmåde til forbedret immunoassay
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
CY1112553T1 (el) Ανοσοπροσδιορισμοι υψηλης ευαισθησιας και κιτια για τον προσδιορισμο πεπτιδιων και πρωτεϊνων βιολογικου ενδιαφεροντος
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
CY1112090T1 (el) Μεθοδος για ανιχνευση βιολογικων οργανισμων με χρηση σκεδασης raman
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
ATE545867T1 (de) I-plastin-testverfahren zur in-vitro-diagnose von kolorektalkarzinom
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
WO2010000467A8 (en) Asc as a marker for lung cancer
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs

Legal Events

Date Code Title Description
8364 No opposition during term of opposition